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Apoptosis: Getting rid of the bodies
Valerie A. Fadok and Peter M. Henson
Cells that die by apoptosis need to be removed before
lysis to preserve tissue integrity and function. Recent
studies have identified components of the uptake
machinery used by phagocytes, but much remains to be
learnt, particularly about the recognition mechanisms
and their coupling to the uptake machinery.
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Programmed cell death, or apoptosis, is now recognized as
a fundamental general process of metazoan development
and physiology. But while in recent years many of the
components of the cell-death machinery have been
identified and characterized, the events that follow
apoptotic cell death have been relatively neglected and
are therefore poorly understood. This has now changed
with a number of publications that shed significant new
light on the mechanisms by which phagocytes recognize
and remove apoptotic cells. 
Regardless of the pathways and mechanisms by which
apoptosis is mediated, the rapid and efficient removal of
apoptotic cells accomplishes the critical goal of significant
cell deletion without tissue damage. Apoptotic cells are
engulfed by their neighbors, as occurs in epithelium, by
mesenchymal cells such as fibroblasts or renal mesangial
cells, or by the ultimate in professional phagocytes, the
macrophages (see Figure 1). Removal before lysis pre-
vents the release of potentially toxic or immunogenic
intracellular contents. In addition, the phagocytosing
macrophage adopts a phenotype which tends to suppress
inflammation and promote repair, as a consequence of the
relatively selective synthesis and secretion of active trans-
forming growth factor β (TGFβ) [1].
The nematode Caenorhabditis elegans has contributed
greatly to our understanding of apoptosis, and it has been
exciting to observe the many parallels that have been
shown to exist between mechanisms of cell death in this
worm and in mammals. Studies of C. elegans genes such as
ced-3 and ced-9 have led to the discovery of large families
of homologous genes — encoding caspases and Bcl-2
family members, respectively — in mammalian cells that
appear to have equivalent functions to their worm proto-
types. Given these observations, it is no surprise then that
the mechanisms mediating the recognition and removal of
apoptotic cells in mammals appear so complicated, as 
C. elegans is known to have at least six genes devoted to
this process, if not more.
The engulfment genes in C. elegans have been divided
into two groups, on the basis of genetic complementarity
and the effects of mutations on cellular migration. Muta-
tions in ced-1, ced-6 or ced-7 inhibit engulfment of apoptotic
bodies. Mutations in ced-2, ced-5 or ced-10 affect this
process, but also alter the migration of gonadal distal tip
cells. The number of persistent apoptotic bodies is
increased dramatically in worms containing mutations in
genes from either group. Three of these genes, ced-5, ced-6
and ced-7, have been cloned recently and potential func-
tions in uptake suggested [2–4]. The Ced-5 and Ced-6
proteins appear to be involved in the physical process of
engulfment, rather than recognition itself; the function of
Ced-7 is less clear. 
The Ced-5 sequence revealed similarity to the mam-
malian protein Dock 180 and the Drosophila protein
known as myoblast city (Mbc) [2]. Transfection experi-
ments, looking for restoration of wild-type engulfment
and migration properties in ced-5 mutant worms, showed
that Ced-5 acts within the engulfing cells, rather than in or
on the target cells. It was suggested that Ced-5, Dock 180
Figure 1
Uptake of two apoptotic mouse thymocytes by a mouse elicited
peritoneal macrophage. The long arrow indicates a late apoptotic cell.
The short arrow indicates an early apoptotic cell, uptake of which
suggests that macrophages recognize surface changes which develop
early in the apoptotic process.
and Mbc may be members of a family of conserved pro-
teins, dubbed the CDM family, which regulate membrane
interactions with the cytoskeleton. CDM proteins might
contribute to the physical process of extending the phago-
cyte’s surface around the apoptotic target. The uptake of
apoptotic cells into macrophages has always seemed to us
to be qualitatively different from the Fc-receptor-medi-
ated uptake of opsonized apoptotic cells or the two or
more mechanisms used to engulf microorganisms by more
‘conventional’ receptors. Does this imply that CDM pro-
teins act in a unique uptake pathway? 
Liu and Hengartner [3] found that overexpression of ced-6
could partially restore phagocytosis in ced-1 or ced-7
mutants, suggesting that Ced-6 acts downstream of Ced-1
and Ced-7. Like Shc, Ced-6 has a phosphotyrosine-
binding domain. As Ced-7 contains a potential tyrosine
phosphorylation site in one of its cytoplasmic domains,
Liu and Hengartner [3] hypothesize that Ced-6 might be
an adaptor molecule that binds to phosphorylated Ced-7.
Whether Ced-7 really is phosphorylated on binding of
apoptotic cells to phagocytes, and whether this is an
important event in the interaction between these two cell
types, remains to be seen.
The existence of a mammalian homologue for Ced-7 was
predicted by Luciani and Chimini [5], in the course of
their work on mammalian ‘ATP-binding cassette’ (ABC)
transporters. They obtained evidence implicating such a
transporter protein, ABC1, in phagocytosis of apoptotic
cells. They found that ABC1 is expressed in macrophages
at sites of apoptosis, such as regressing mouse limb buds,
and that antibodies against the ATP-binding region of this
transporter protein blocked the phagocytosis of apoptotic
cells by macrophages. Furthermore, Luciani and Chimini
[5] compared the sequence of the ABC1 transporter with
the predicted open-reading frames from chromosome III
of C. elegans, which was known to contain the ced-7 locus;
they identified a coding region for a protein similar to ABC
transporters that mapped very closely to the ced-7 locus,
and suggested that this might be the ced-7 gene itself.
The cloning of ced-7 confirmed the similarity of its product
to the ABC1 transporter by showing that Ced-7 contains
the characteristic hydrophobic domain between the two
halves of the protein [4]. Surprisingly, Wu and Horvitz [4]
were able to show by mosaic analysis that Ced-7 acts in
both the target cell and the engulfing cell. Using an
antibody against the Ced-7 protein, they found that it is
localized to the plasma membrane, and suggest that homo-
typic interactions between cell-surface Ced-7 molecules
may mediate adhesion between macrophages and target
cells. The exact functions of Ced-7 and ABC1 remain to be
determined; for example, whether they are involved in
tethering macrophages to their target cells or the uptake
process per se is still to be resolved. 
The homologies between C. elegans ced genes and
mammalian genes involved in phagocytosis are comforting
and support the notion that molecular mechanisms for
phagocytosis of apoptotic cells have been conserved,
perhaps throughout the metazoa. As mentioned, Ced-5
and Ced-6 appear to be part of the uptake mechanism
itself; C. elegans molecules that mediate the recognition of
apoptotic cells remain to be identified. More is known
about the recognition process in mammals, but the process
appears rather complex. At least six quite different groups
of receptors have been implicated in the recognition of
apoptotic cells, including some that might have other func-
tions and have been co-opted as indicators of apoptosis. 
Devitt et al. [6] found that CD14, which appears to be the
major receptor for bacterial lipopolysaccharide (LPS),
mediates binding of apoptotic lymphocytes. When
expressed in transfected Cos-1 cells, CD14 was able to
mediate increased binding and uptake of apoptotic cells,
which was inhibited by a subset of anti-CD14 antibodies.
The uptake efficiency was low compared to that for
macrophages, however, suggesting that CD14 provides
only recognition and needs to engage additional molecules
for uptake. Interestingly, binding of apoptotic cells, unlike
activation by LPS, failed to stimulate production of
tumour necrosis factor-α (TNFα), even though epitope
mapping suggested that apoptotic cells bind to a site on
CD14 very close to that which interacts with LPS. This
involvement of an LPS ‘receptor’ in the non-inflammatory
uptake of apoptotic cells is interesting: either the signal
transduction machinery that associates with CD14 varies
with the ligand it binds, as suggested by Devitt et al. [6], or
another receptor that co-operatively binds to the apoptotic
cells along with the CD14 inhibits the signaling pathways
from the latter which normally lead to the production of
inflammatory mediators.
Most of the mechanisms that have been reported to
mediate uptake of apoptotic cells in mammals are associ-
ated with recognition, rather than the physical process of
uptake itself. Savill [7] has suggested that these mam-
malian recognition receptors can be divided into those
that tether the apoptotic cells, which would include
CD14, lectins and scavenger receptor A, and those that are
actual transmembrane signaling molecules, such as αvβ3
integrin, CD36 and ABC1. How any of these receptors
interact with the surface of an apoptotic cell, and with
each other, is not known. We also know very little about
the mechanisms used by semi-professional and amateur
phagocytes, yet in most tissue remodeling these cells
might carry out the initial engulfment of apoptotic cells
prior to the influx and maturation of macrophages.
Even less is known about the nature of the ligands on the
apoptotic cells to which these receptors bind. The most
universally accepted surface change would appear to be
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exposure of phosphatidylserine following loss of membrane
aminophosholipid asymmetry [8]. We favor the idea that
phosphatidylserine plays a direct role in recognition. Loss
of phospholipid asymmetry could, however, also allow the
exposure of otherwise cryptic antigens which mark the cell
for removal. Exposure of sugar residues, such as mannose
and galactose, has been demonstrated on apoptotic cells by
Dini et al. [9], who have shown that sugar–lectin interac-
tions might be important in the uptake of apoptotic cells in
the liver. The surfaces of a variety of apoptotic cells need to
be probed thoroughly to determine whether all apoptotic
cells look alike to the potential phagocyte, or whether
target cell differences truly occur.
At this point, it would appear that analysis of Ced-5, Ced-6
and Ced-7 has provided information about the physical
machinery associated with the act of engulfment, yet vir-
tually nothing is known about how the worm’s phagocytes
recognize their apoptotic targets. By contrast, several
receptors have been identified on mammalian phagocytes
which mediate the recognition of apoptotic cells, but how
they are coupled to uptake is not known. One of the press-
ing mysteries has been the reason for so many different
receptors, particularly on the macrophage. Are the surfaces
of apoptotic cells truly that complex and that variable? 
We suggest that the surfaces of apoptotic cells are
characterized by basic changes which are preserved across
phylogeny, although there may be quantitative differences
among cell types. These could include altered phospho-
lipid asymmetry and altered glycosylation, either or both
of which could directly, or via exposure of cryptic antigens,
contribute to a complex signal. Amateur phagocytes might
thus recognize and engulf apoptotic target cells using
simple receptors, such as lectins or perhaps conserved
phosphatidylserine-binding proteins. It also seems reason-
able to suggest that macrophages might use additional
receptors, perhaps associated together in an apoptotic-cell-
recognizing complex (see [10,11]) that improves efficiency
by binding to multiple ligands to mediate the extremely
efficient uptake of which these cells are capable. 
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